[1] X. Kang, Y. Li, M. Zhu, R. Jin, Atomically precise alloy nanoclusters: syntheses, structures, and properties. Chem. Soc. Rev. 49(17), 6443–6514 (2020).

[2] L. Zhang, E. Wang, Metal nanoclusters: new fluorescent probes for sensors and bioimaging. Nano Today 9(1), 132–157 (2014).

[3] R. Jin, Atomically precise metal nanoclusters: stable sizes and optical properties. Nanoscale 7(5), 1549–1565 (2015).

[4] X. Luo, J. Liu, Ultrasmall luminescent metal nanoparticles: surface engineering strategies for biological targeting and imaging. Adv. Sci. 9(3), e2103971 (2022).

[5] Y. Huang, L. Fuksman, J. Zheng, Luminescence mechanisms of ultrasmall gold nanoparticles. Dalton Trans. 47(18), 6267–6273 (2018).

[6] K. Pyo, V.D. Thanthirige, K. Kwak, P. Pandurangan, G. Ramakrishna et al., Ultrabright luminescence from gold nanoclusters: rigidifying the Au(I)-thiolate shell. J. Am. Chem. Soc. 137(25), 8244–8250 (2015).

[7] L. Howard-Fabretto, G.G. Andersson, Metal clusters on semiconductor surfaces and application in catalysis with a focus on Au and Ru. Adv. Mater. 32(18), e1904122 (2020).

[8] H. Qian, M. Zhu, Z. Wu, R. Jin, Quantum sized gold nanoclusters with atomic precision. Acc. Chem. Res. 45(9), 1470–1479 (2012).

[9] T. Zhou, X. Jiang, Modulating luminescence and assembled shapes of ultrasmall Au nanoparticles towards hierarchical information encryption. Chem. Sci. 13(41), 12107–12113 (2022).

[10] H. Ma, X. Zhang, L. Liu, Y. Huang, S. Sun et al., Bioactive NIR-II gold clusters for three-dimensional imaging and acute inflammation inhibition. Sci. Adv. 9(31), eadh7828 (2023).

[11] M. Yu, J. Xu, J. Zheng, Renal clearable luminescent gold nanoparticles: From the bench to the clinic. Angew. Chem. Int. Ed. 58(13), 4112–4128 (2019).

[12] J. Liu, M. Yu, C. Zhou, J. Zheng, Renal clearable inorganic nanoparticles: a new frontier of bionanotechnology. Mater. Today 16(12), 477–486 (2013).

[13] L. Shang, G.U. Nienhaus, Gold nanoclusters as novel optical probes for in vitro and in vivo fluorescence imaging. Biophys. Rev. 4(4), 313–322 (2012).

[14] H. Zhang, R. Peng, Y. Luo, Q. Cui, F. Gong et al., In situ synthesis of gold nanoclusters in covalent organic frameworks with enhanced photodynamic properties and antibacterial performance. ACS Appl. Bio Mater. 5(6), 3115–3125 (2022).

[15] A. Master, M. Livingston, A. Sen Gupta, Photodynamic nanomedicine in the treatment of solid tumors: perspectives and challenges. J. Controll. Release 168(1), 88–102 (2013).

[16] H. Deng, Y. Zhong, M. Du, Q. Liu, Z. Fan et al., Theranostic self-assembly structure of gold nanoparticles for NIR photothermal therapy and X-ray computed tomography imaging. Theranostics 4(9), 904–918 (2014).

[17] T.-T. Jia, B.-J. Li, G. Yang, Y. Hua, J.-Q. Liu et al., Enantiomeric alkynyl-protected Au10 clusters with chirality-dependent radiotherapy enhancing effects. Nano Today 39, 101222 (2021).

[18] M.P. Antosh, D.D. Wijesinghe, S. Shrestha, R. Lanou, Y.H. Huang et al., Enhancement of radiation effect on cancer cells by gold-phlip. Proc. Natl. Acad. Sci. U.S.A. 112(17), 5372–5376 (2015).

[19] M. Tavakkoli Yaraki, B. Liu, Y.N. Tan, Emerging strategies in enhancing singlet oxygen generation of nano-photosensitizers toward advanced phototherapy. Nano-Micro Lett. 14(1), 123 (2022).

[20] Q. Fu, X. Zhang, J. Song, H. Yang, Plasmonic gold nanoagents for cancer imaging and therapy. View 2(5), 20200149 (2021).

[21] Y. Yang, Y. Peng, C. Lin, L. Long, J. Hu et al., Human ACE2-functionalized gold “virus-trap” nanostructures for accurate capture of SARS-COV-2 and single-virus sers detection. Nano-Micro Lett. 13(1), 109 (2021).

[22] M. Tavakkoli Yaraki, M. Wu, E. Middha, W. Wu, S. Daqiqeh Rezaei et al., Gold nanostars-AIE theranostic nanodots with enhanced fluorescence and photosensitization towards effective image-guided photodynamic therapy. Nano-Micro Lett. 13(1), 58 (2021).

[23] M. Sharifi, F. Attar, A.A. Saboury, K. Akhtari, N. Hooshmand et al., Plasmonic gold nanoparticles: optical manipulation, imaging, drug delivery and therapy. J. Controll Release 311–312, 170–189 (2019).

[24] A. Lindsey-Crosthwait, D. Rodriguez-Lema, M. Walko, C.M. Pask, A.J. Wilson, Structural optimization of reversible dibromomaleimide peptide stapling. Pept. Sci. 113(1), e24157 (2021).

[25] G. Li, B. Sun, Y. Li, C. Luo, Z. He et al., Small-molecule prodrug nanoassemblies: an emerging nanoplatform for anticancer drug delivery. Small 17(52), e2101460 (2021).

[26] X. Huang, J. Song, B.C. Yung, X. Huang, Y. Xiong et al., Ratiometric optical nanoprobes enable accurate molecular detection and imaging. Chem. Soc. Rev. 47(8), 2873–2920 (2018).

[27] J. Cardellini, A. Ridolfi, M. Donati, V. Giampietro, M. Severi et al., Probing the coverage of nanoparticles by biomimetic membranes through nanoplasmonics. J. Colloid Interface Sci. 640, 100–109 (2023).

[28] L. Zhang, L. Wang, S. He, C. Zhu, Z. Gong et al., High-performance organic electrochemical transistor based on photo-annealed plasmonic gold nanoparticle-doped PEDOT:PSS. ACS Appl. Mater. Interfaces 15(2), 3224–3234 (2023).

[29] Y. Zhou, X. Yang, J. Zhang, S. Xu, J. Li et al., Small molecule fluorescent probes for the detection of reactive nitrogen species in biological systems. Coord. Chem. Rev. 493, 215258 (2023).

[30] Y. Su, B. Yu, S. Wang, H. Cong, Y. Shen, NIR-II bioimaging of small organic molecule. Biomaterials 271, 120717 (2021).

[31] X. Liu, B. Yu, Y. Shen, H. Cong, Design of NIR-II high performance organic small molecule fluorescent probes and summary of their biomedical applications. Coord. Chem. Rev. 468, 214609 (2022).

[32] J. Lou-Franco, B. Das, C. Elliott, C. Cao, Gold nanozymes: from concept to biomedical applications. Nano-Micro Lett. 13(1), 10 (2020).

[33] S.M. van de Looij, E.R. Hebels, M. Viola, M. Hembury, S. Oliveira et al., Gold nanoclusters: imaging, therapy, and theranostic roles in biomedical applications. Bioconjugate Chem. 33(1), 4–23 (2022).

[34] X. Wang, H. He, Y. Wang, J. Wang, X. Sun et al., Active tumor-targeting luminescent gold clusters with efficient urinary excretion. Chem. Commun. 52(59), 9232–9235 (2016).

[35] H. Chen, S. Li, B. Li, X. Ren, S. Li et al., Folate-modified gold nanoclusters as near-infrared fluorescent probes for tumor imaging and therapy. Nanoscale 4(19), 6050–6064 (2012).

[36] P. Zhang, X.X. Yang, Y. Wang, N.W. Zhao, Z.H. Xiong et al., Rapid synthesis of highly luminescent and stable Au20 nanoclusters for active tumor-targeted imaging in vitro and in vivo. Nanoscale 6(4), 2261–2269 (2014).

[37] M. Jiang, Y. Lin, X. Fang, M. Liu, L. Ma et al., Enhancement of gold-nanocluster-mediated chemotherapeutic efficiency of cisplatin in lung cancer. J. Mater. Chem. B 9(24), 4895–4905 (2021).

[38] M. Fan, Y. Han, S. Gao, H. Yan, L. Cao et al., Ultrasmall gold nanoparticles in cancer diagnosis and therapy. Theranostics 10(11), 4944–4957 (2020).

[39] Y. Li, O. Zaluzhna, B. Xu, Y. Gao, J.M. Modest et al., Mechanistic insights into the brust-schiffrin two-phase synthesis of organo-chalcogenate-protected metal nanoparticles. J. Am. Chem. Soc. 133(7), 2092–2095 (2011).

[40] C.J. Ackerson, P.D. Jadzinsky, R.D. Kornberg, Thiolate ligands for synthesis of water-soluble gold clusters. J. Am. Chem. Soc. 127(18), 6550–6551 (2005).

[41] R.H. Adnan, J.M.L. Madridejos, A.S. Alotabi, G.F. Metha, G.G. Andersson, A review of state of the art in phosphine ligated gold clusters and application in catalysis. Adv. Sci. 9(15), 2105692 (2022).

[42] Z.-H. Gao, K. Wei, T. Wu, J. Dong, D.-E. Jiang et al., A heteroleptic gold hydride nanocluster for efficient and selective electrocatalytic reduction of CO2 to CO. J. Am. Chem. Soc. 144(12), 5258–5262 (2022).

[43] J.J. Li, Z.J. Guan, S.F. Yuan, F. Hu, Q.M. Wang, Enriching structural diversity of alkynyl-protected gold nanoclusters with chlorides. Angew. Chem. Int. Ed. 60(12), 6699–6703 (2021).

[44] Z.-J. Guan, F. Hu, J.-J. Li, Z.-R. Wen, Y.-M. Lin et al., Isomerization in alkynyl-protected gold nanoclusters. J. Am. Chem. Soc. 142(6), 2995–3001 (2020).

[45] K.L.D.M. Weerawardene, P. Pandeya, M. Zhou, Y. Chen, R. Jin et al., Luminescence and electron dynamics in atomically precise nanoclusters with eight superatomic electrons. J. Am. Chem. Soc. 141(47), 18715–18726 (2019).

[46] D.M. Chevrier, L. Raich, C. Rovira, A. Das, Z. Luo et al., Molecular-scale ligand effects in small gold-thiolate nanoclusters. J. Am. Chem. Soc. 140(45), 15430–15436 (2018).

[47] W. Kurashige, Y. Niihori, S. Sharma, Y. Negishi, Precise synthesis, functionalization and application of thiolate-protected gold clusters. Coord. Chem. Rev. 320–321, 238–250 (2016).

[48] Z. Wu, M.A. MacDonald, J. Chen, P. Zhang, R. Jin, Kinetic control and thermodynamic selection in the synthesis of atomically precise gold nanoclusters. J. Am. Chem. Soc. 133(25), 9670–9673 (2011).

[49] M. Zhu, E. Lanni, N. Garg, M.E. Bier, R. Jin, Kinetically controlled, high-yield synthesis of Au25 clusters. J. Am. Chem. Soc. 130(4), 1138–1139 (2008).

[50] T. Chen, Q. Yao, R.R. Nasaruddin, J. Xie, Electrospray ionization mass spectrometry: A powerful platform for noble-metal nanocluster analysis. Angew. Chem. Int. Ed. 58(35), 11967–11977 (2019).

[51] C. Zeng, Y. Chen, K. Kirschbaum, K. Appavoo, M.Y. Sfeir et al., Structural patterns at all scales in a nonmetallic chiral Au133(SR)52 nanoparticle. Sci. Adv. 1(2), e1500045 (2015).

[52] Z. Luo, V. Nachammai, B. Zhang, N. Yan, D.T. Leong et al., Toward understanding the growth mechanism: tracing all stable intermediate species from reduction of Au(I)-thiolate complexes to evolution of Au25 nanoclusters. J. Am. Chem. Soc. 136(30), 10577–10580 (2014).

[53] H. Lee, S.M. Dellatore, W.M. Miller, P.B. Messersmith, Mussel-inspired surface chemistry for multifunctional coatings. Science 318(5849), 426–430 (2007).

[54] A. Dass, S. Theivendran, P.R. Nimmala, C. Kumara, V.R. Jupally et al., Au133(SPh-tBu)52 nanomolecules: X-ray crystallography, optical, electrochemical, and theoretical analysis. J. Am. Chem. Soc. 137(14), 4610–4613 (2015).

[55] Z. Liu, Z. Wu, Q. Yao, Y. Cao, O.J.H. Chai et al., Correlations between the fundamentals and applications of ultrasmall metal nanoclusters: recent advances in catalysis and biomedical applications. Nano Today 36, 101053 (2021).

[56] S. Han, T. Zal, K.V. Sokolov, Fate of antibody-targeted ultrasmall gold nanoparticles in cancer cells after receptor-mediated uptake. ACS Nano 15(6), 9495–9508 (2021).

[57] Y. Huang, W. Xiao, S. Ahrari, M. Yu, J. Zheng, Crosstalk between hepatic glutathione efflux and tumor targeting of ICG-conjugated gold nanoparticles. Angew. Chem. Int. Ed. (2023).

[58] N. Xia, Z. Wu, Controlling ultrasmall gold nanoparticles with atomic precision. Chem. Sci. 12(7), 2368–2380 (2021).

[59] N. Goswami, Q. Yao, T. Chen, J. Xie, Mechanistic exploration and controlled synthesis of precise thiolate-gold nanoclusters. Coord. Chem. Rev. 329, 1–15 (2016).

[60] J. Zheng, C. Zhou, M. Yu, J. Liu, Different sized luminescent gold nanoparticles. Nanoscale 4(14), 4073–4083 (2012).

[61] Y. Du, H. Sheng, D. Astruc, M. Zhu, Atomically precise noble metal nanoclusters as efficient catalysts: a bridge between structure and properties. Chem. Rev. 120(2), 526–622 (2019).

[62] X. Kang, M. Zhu, Tailoring the photoluminescence of atomically precise nanoclusters. Chem. Soc. Rev. 48(8), 2422–2457 (2019).

[63] X. Jiang, B. Du, Y. Huang, J. Zheng, Ultrasmall noble metal nanoparticles: breakthroughs and biomedical implications. Nano Today 21, 106–125 (2018).

[64] L. Gong, Y. Wang, J. Liu, Bioapplications of renal-clearable luminescent metal nanoparticles. Biomater. Sci. 5(8), 1393–1406 (2017).

[65] X. Song, W. Zhu, X. Ge, R. Li, S. Li et al., A new class of NIR-II gold nanocluster-based protein biolabels for in vivo tumor-targeted imaging. Angew. Chem. Int. Ed. 60(3), 1306–1312 (2021).

[66] G. Yang, X. Mu, X. Pan, Y. Tang, Q. Yao et al., Ligand engineering of Au44 nanoclusters for NIR-II luminescent and photoacoustic imaging-guided cancer photothermal therapy. Chem. Sci. 14(16), 4308–4318 (2023).

[67] J.H. Yu, M.S. Jeong, E.O. Cruz, I.S. Alam, S.K. Tumbale et al., Highly excretable gold supraclusters for translatable in vivo raman imaging of tumors. ACS Nano 17(3), 2554–2567 (2023).

[68] Y. Wang, C. Xu, J. Zhai, F. Gao, R. Liu et al., Label-free Au cluster used for in vivo 2D and 3D computed tomography of murine kidneys. Anal. Chem. 87(1), 343–345 (2015).

[69] E.P. Stater, A.Y. Sonay, C. Hart, J. Grimm, The ancillary effects of nanoparticles and their implications for nanomedicine. Nat. Nanotechnol. 16(11), 1180–1194 (2021).

[70] Y. Liu, J. Wang, Q. Xiong, D. Hornburg, W. Tao et al., Nano-bio interactions in cancer: from therapeutics delivery to early detection. Acc. Chem. Res. 54(2), 291–301 (2020).

[71] M.J. Mitchell, M.M. Billingsley, R.M. Haley, M.E. Wechsler, N.A. Peppas et al., Engineering precision nanoparticles for drug delivery. Nat. Rev. Drug Discovery 20(2), 101–124 (2021).

[72] J. Lin, H. Zhang, Z. Chen, Y. Zheng, Penetration of lipid membranes by gold nanoparticles: insights into cellular uptake, cytotoxicity, and their relationship. ACS Nano 4(9), 5421–5429 (2010).

[73] L.W.C. Ho, Y. Liu, R. Han, Q. Bai, C.H.J. Choi, Nano-cell interactions of non-cationic bionanomaterials. Acc. Chem. Res. 52(6), 1519–1530 (2019).

[74] A. Verma, F. Stellacci, Effect of surface properties on nanoparticle-cell interactions. Small 6(1), 12–21 (2010).

[75] M. Wen, J. Li, W. Zhong, J. Xu, S. Qu et al., High-throughput colorimetric analysis of nanoparticle-protein interactions based on the enzyme-mimic properties of nanoparticles. Anal. Chem. 94(24), 8783–8791 (2022).

[76] J. Zhu, Z. Zhao, H. Chen, X. Chen, J. Liu, Surface-regulated injection dose response of ultrasmall luminescent gold nanoparticles. Nanoscale 14(24), 8818–8824 (2022).

[77] H.S. Han, J.D. Martin, J. Lee, D.K. Harris, D. Fukumura et al., Spatial charge configuration regulates nanoparticle transport and binding behavior in vivo. Angew. Chem. Int. Ed. 52(5), 1414–1419 (2013).

[78] Z.J. Zhu, P.S. Ghosh, O.R. Miranda, R.W. Vachet, V.M. Rotello, Multiplexed screening of cellular uptake of gold nanoparticles using laser desorption/ionization mass spectrometry. J. Am. Chem. Soc. 130(43), 14139–14143 (2008).

[79] D.B. Chithrani, Intracellular uptake, transport, and processing of gold nanostructures. Mol. Membr. Biol. 27(7), 299–311 (2010).

[80] L.C. Cheng, X. Jiang, J. Wang, C. Chen, R.S. Liu, Nano-bio effects: interaction of nanomaterials with cells. Nanoscale 5(9), 3547–3569 (2013).

[81] S. Behzadi, V. Serpooshan, W. Tao, M.A. Hamaly, M.Y. Alkawareek et al., Cellular uptake of nanoparticles: Journey inside the cell. Chem. Soc. Rev. 46(14), 4218–4244 (2017).

[82] W.G. Kreyling, A.M. Abdelmonem, Z. Ali, F. Alves, M. Geiser et al., In vivo integrity of polymer-coated gold nanoparticles. Nat. Nanotechnol. 10(7), 619–623 (2015).

[83] Y. Li, S. Qu, Y. Xue, L. Zhang, L. Shang, Cationic antibacterial metal nanoclusters with traceable capability for fluorescent imaging the nano-bio interactions. Nano Res. 16(1), 999–1008 (2022).

[84] C. Shen, Y. Xue, Y. Li, M. Wei, M. Wen et al., Kinetically regulated one-pot synthesis of cationic gold nanoparticles and their size-dependent antibacterial mechanism. J. Mate. Sci. Technol. 162, 145–156 (2023).

[85] E.C. Cho, J. Xie, P.A. Wurm, Y. Xia, Understanding the role of surface charges in cellular adsorption versus internalization by selectively removing gold nanoparticles on the cell surface with a I2/KI etchant. Nano Lett. 9(3), 1080–1084 (2009).

[86] Y. Jiang, S. Huo, T. Mizuhara, R. Das, Y.W. Lee et al., The interplay of size and surface functionality on the cellular uptake of sub-10 nm gold nanoparticles. ACS Nano 9(10), 9986–9993 (2015).

[87] M. Yu, C. Zhou, J. Liu, J.D. Hankins, J. Zheng, Luminescent gold nanoparticles with pH-dependent membrane adsorption. J. Am. Chem. Soc. 133(29), 11014–11017 (2011).

[88] J. Zhu, K. He, Z. Dai, L. Gong, T. Zhou et al., Self-assembly of luminescent gold nanoparticles with sensitive pH-stimulated structure transformation and emission response toward lysosome escape and intracellular imaging. Anal. Chem. 91(13), 8237–8243 (2019).

[89] N.M. Schaeublin, L.K. Braydich-Stolle, A.M. Schrand, J.M. Miller, J. Hutchison et al., Surface charge of gold nanoparticles mediates mechanism of toxicity. Nanoscale 3(2), 410–420 (2011).

[90] C. Kim, S.S. Agasti, Z. Zhu, L. Isaacs, V.M. Rotello, Recognition-mediated activation of therapeutic gold nanoparticles inside living cells. Nat. Chem. 2(11), 962–966 (2010).

[91] L.M. Koch, E.S. Birkeland, S. Battaglioni, X. Helle, M. Meerang et al., Cytosolic pH regulates proliferation and tumour growth by promoting expression of cyclin D1. Nat. Metab. 2(11), 1212–1222 (2020).

[92] B.A. Webb, M. Chimenti, M.P. Jacobson, D.L. Barber, Dysregulated pH: a perfect storm for cancer progression. Nat. Rev. Cancer 11(9), 671–677 (2011).

[93] T. Mizuhara, K. Saha, D.F. Moyano, C.S. Kim, B. Yan et al., Acylsulfonamide-functionalized zwitterionic gold nanoparticles for enhanced cellular uptake at tumor pH. Angew. Chem. Int. Ed. 54(22), 6567–6570 (2015).

[94] L. Gong, Y. Chen, K. He, J. Liu, Surface coverage-regulated cellular interaction of ultrasmall luminescent gold nanoparticles. ACS Nano 13(2), 1893–1899 (2019).

[95] A. Verma, O. Uzun, Y. Hu, Y. Hu, H.S. Han et al., Surface-structure-regulated cell-membrane penetration by monolayer-protected nanoparticles. Nat. Mater. 7(7), 588–595 (2008).

[96] Y.F. Huang, H. Liu, X. Xiong, Y. Chen, W. Tan, Nanoparticle-mediated lgE-receptor aggregation and signaling in RBL mast cells. J. Am. Chem. Soc. 131(47), 17328–17334 (2009).

[97] H. Liu, T.L. Doane, Y. Cheng, F. Lu, S. Srinivasan et al., Control of surface ligand density on pegylated gold nanoparticles for optimized cancer cell uptake. Part. Part. Syst. Charact. 32(2), 197–204 (2015).

[98] L.W.C. Ho, B. Yin, G. Dai, C.H.J. Choi, Effect of surface modification with hydrocarbyl groups on the exocytosis of nanoparticles. Biochemistry 60(13), 1019–1030 (2021).

[99] V. Mailander, K. Landfester, Interaction of nanoparticles with cells. Biomacromol 10(9), 2379–2400 (2009).

[100] H.T. McMahon, E. Boucrot, Molecular mechanism and physiological functions of clathrin-mediated endocytosis. Nat. Rev. Mol. Cell Biol. 12(8), 517–533 (2011).

[101] Y. Guo, E. Terazzi, R. Seemann, J.B. Fleury, V.A. Baulin, Direct proof of spontaneous translocation of lipid-covered hydrophobic nanoparticles through a phospholipid bilayer. Sci. Adv. 2(11), e1600261 (2016).

[102] S. Sun, Y. Huang, C. Zhou, S. Chen, M. Yu et al., Effect of hydrophobicity on nano-bio interactions of zwitterionic luminescent gold nanoparticles at the cellular level. Bioconjugate Chem. 29(6), 1841–1846 (2018).

[103] D.F. Moyano, M. Goldsmith, D.J. Solfiell, D. Landesman-Milo, O.R. Miranda et al., Nanoparticle hydrophobicity dictates immune response. J. Am. Chem. Soc. 134(9), 3965–3967 (2012).

[104] A. Chompoosor, K. Saha, P.S. Ghosh, D.J. Macarthy, O.R. Miranda et al., The role of surface functionality on acute cytotoxicity, ros generation and DNA damage by cationic gold nanoparticles. Small 6(20), 2246–2249 (2010).

[105] J. Zhai, L. Zhao, L. Zheng, F. Gao, L. Gao et al., Peptide-Au cluster probe: precisely detecting epidermal growth factor receptor of three tumor cell lines at a single-cell level. ACS Omega 2(1), 276–282 (2017).

[106] L. Zhao, J. Zhai, X. Zhang, X. Gao, X. Fang et al., Computational design of peptide-Au cluster probe for sensitive detection of αIIbβ3 integrin. Nanoscale 8(7), 4203–4208 (2016).

[107] F. Xiao, Y. Chen, J. Qi, Q. Yao, J. Xie et al., Multi-targeted peptide-modified gold nanoclusters for treating solid tumors in the liver. Adv. Mater. 35(20), 2210412 (2023).

[108] E.S. Kryachko, F. Remacle, Complexes of DNA bases and gold clusters Au3 and Au4 involving nonconventional N-H…Au hydrogen bonding. Nano Lett. 5(4), 735–739 (2005).

[109] V. Rojas-Cervellera, L. Raich, J. Akola, C. Rovira, The molecular mechanism of the ligand exchange reaction of an antibody against a glutathione-coated gold cluster. Nanoscale 9(9), 3121–3127 (2017).

[110] A. Retnakumari, J. Jayasimhan, P. Chandran, D. Menon, S. Nair et al., CD33 monoclonal antibody conjugated Au cluster nano-bioprobe for targeted flow-cytometric detection of acute myeloid leukaemia. Nanotechnology 22(28), 285102 (2011).

[111] Z. Dai, Y. Tan, K. He, H. Chen, J. Liu, Strict DNA valence control in ultrasmall thiolate-protected near-infrared-emitting gold nanoparticles. J. Am. Chem. Soc. 142(33), 14023–14027 (2020).

[112] Y. Pan, Q. Li, Q. Zhou, W. Zhang, P. Yue et al., Cancer cell specific fluorescent methionine protected gold nanoclusters for in-vitro cell imaging studies. Talanta 188, 259–265 (2018).

[113] Y. Yang, S. Wang, S. Chen, Y. Shen, M. Zhu, Switching the subcellular organelle targeting of atomically precise gold nanoclusters by modifying the capping ligand. Chem. Commun. 54(66), 9222–9225 (2018).

[114] A. Nagy, N.L. Robbins, The hurdles of nanotoxicity in transplant nanomedicine. Nanomedicine 14(20), 2749–2762 (2019).

[115] Y. Wang, T. Yang, Q. He, Strategies for engineering advanced nanomedicines for gas therapy of cancer. Natl. Sci. Rev. 7(9), 1485–1512 (2020).

[116] O. Bar-Ilan, R.M. Albrecht, V.E. Fako, D.Y. Furgeson, Toxicity assessments of multisized gold and silver nanoparticles in zebrafish embryos. Small 5(16), 1897–1910 (2009).

[117] R. Coradeghini, S. Gioria, C.P. Garcia, P. Nativo, F. Franchini et al., Size-dependent toxicity and cell interaction mechanisms of gold nanoparticles on mouse fibroblasts. Toxicol. Lett. 217(3), 205–216 (2013).

[118] C.M. Goodman, C.D. McCusker, T. Yilmaz, V.M. Rotello, Toxicity of gold nanoparticles functionalized with cationic and anionic side chains. Bioconjugate Chem. 15(4), 897–900 (2004).

[119] L. Gong, K. He, J. Liu, Concentration-dependent subcellular distribution of ultrasmall near-infrared-emitting gold nanoparticles. Angew. Chem. Int. Ed. 60(11), 5739–5743 (2021).

[120] W. Poon, B.R. Kingston, B. Ouyang, W. Ngo, W.C.W. Chan, A framework for designing delivery systems. Nat. Nanotechnol. 15(10), 819–829 (2020).

[121] Y. Zhang, Y. Bai, J. Jia, N. Gao, Y. Li et al., Perturbation of physiological systems by nanoparticles. Chem. Soc. Rev. 43(10), 3762–3809 (2014).

[122] Y.N. Zhang, W. Poon, A.J. Tavares, I.D. McGilvray, W.C.W. Chan, Nanoparticle-liver interactions: cellular uptake and hepatobiliary elimination. J. Controll.Release 240, 332–348 (2016).

[123] S. Wilhelm, A.J. Tavares, Q. Dai, S. Ohta, J. Audet et al., Analysis of nanoparticle delivery to tumours. Nat. Rev. Mater. 1(5), 16014 (2016).

[124] S.G. Elci, Y. Jiang, B. Yan, S.T. Kim, K. Saha et al., Surface charge controls the suborgan biodistributions of gold nanoparticles. ACS Nano 10(5), 5536–5542 (2016).

[125] K.M. Tsoi, S.A. MacParland, X.Z. Ma, V.N. Spetzler, J. Echeverri et al., Mechanism of hard-nanomaterial clearance by the liver. Nat. Mater. 15(11), 1212–1221 (2016).

[126] J. Wang, J.J. Masehi-Lano, E.J. Chung, Peptide and antibody ligands for renal targeting: Nanomedicine strategies for kidney disease. Biomater. Sci. 5(8), 1450–1459 (2017).

[127] Y. Huang, J. Wang, K. Jiang, E.J. Chung, Improving kidney targeting: The influence of nanoparticle physicochemical properties on kidney interactions. J. Controll. Release 334, 127–137 (2021).

[128] Q. Chen, F. Ding, S. Zhang, Q. Li, X. Liu et al., Sequential therapy of acute kidney injury with a DNA nanodevice. Nano Lett. 21(10), 4394–4402 (2021).

[129] B. Haraldsson, J. Nyström, W.M. Deen, Properties of the glomerular barrier and mechanisms of proteinuria. Physiol. Rev. 88(2), 451–487 (2008).

[130] B. Du, X. Jiang, A. Das, Q. Zhou, M. Yu et al., Glomerular barrier behaves as an atomically precise bandpass filter in a sub-nanometre regime. Nat. Nanotechnol. 12(11), 1096–1102 (2017).

[131] B. Du, M. Yu, J. Zheng, Transport and interactions of nanoparticles in the kidneys. Nat. Rev. Mater. 3(10), 358–374 (2018).

[132] F. Oroojalian, F. Charbgoo, M. Hashemi, A. Amani, R. Yazdian-Robati et al., Recent advances in nanotechnology-based drug delivery systems for the kidney. J. Controll. Release 321, 442–462 (2020).

[133] B.A. Molitoris, R.M. Sandoval, S.P.S. Yadav, M.C. Wagner, Albumin uptake and processing by the proximal tubule: physiological, pathological, and therapeutic implications. Physiol. Rev. 102(4), 1625–1667 (2022).

[134] Y. Huang, M. Yu, J. Zheng, Proximal tubules eliminate endocytosed gold nanoparticles through an organelle-extrusion-mediated self-renewal mechanism. Nat. Nanotechnol. 18(6), 637–646 (2023).

[135] J. Huang, J. Li, Y. Lyu, Q. Miao, K. Pu, Molecular optical imaging probes for early diagnosis of drug-induced acute kidney injury. Nat. Mater. 18(10), 1133–1143 (2019).

[136] Y. Tan, M. Chen, H. Chen, J. Wu, J. Liu, Enhanced ultrasound contrast of renal-clearable luminescent gold nanoparticles. Angew. Chem. Int. Ed. 60(21), 11713–11717 (2021).

[137] F.A. Blocki, P.M. Schlievert, L.P. Wackett, Rat liver protein linking chemical and immunological detoxification systems. Nature 360(6401), 269–270 (1992).

[138] H. Wang, C.A. Thorling, X. Liang, K.R. Bridle, J.E. Grice et al., Diagnostic imaging and therapeutic application of nanoparticles targeting the liver. J. Mater. Chem. B 3(6), 939–958 (2015).

[139] W. Poon, Y.-N. Zhang, B. Ouyang, B.R. Kingston, J.L.Y. Wu et al., Elimination pathways of nanoparticles. ACS Nano 13(5), 5785–5798 (2019).

[140] A. Boey, H.K. Ho, All roads lead to the liver: metal nanoparticles and their implications for liver health. Small 16(21), e2000153 (2020).

[141] W. Cai, Y. Tan, K. He, B. Tang, J. Liu, Manganese(II)-guided separation in the sub-nanometer regime for precise identification of in vivo size dependence. Angew. Chem. Int. Ed. 62(10), e202214720 (2023).

[142] X. Jiang, B. Du, J. Zheng, Glutathione-mediated biotransformation in the liver modulates nanoparticle transport. Nat. Nanotechnol. 14(9), 874–882 (2019).

[143] X. Jiang, Q. Zhou, B. Du, S. Li, Y. Huang et al., Noninvasive monitoring of hepatic glutathione depletion through fluorescence imaging and blood testing. Sci. Adv. (2021).

[144] Z. Zhao, H. Chen, K. He, J. Lin, W. Cai et al., Glutathione-activated emission of ultrasmall gold nanoparticles in the second near-infrared window for imaging of early kidney injury. Anal. Chem. 95(11), 5061–5068 (2023).

[145] Y. Tan, W. Cai, C. Luo, J. Tang, R.T.K. Kwok et al., Rapid biotransformation of luminescent bimetallic nanoparticles in hepatic sinusoids. J. Am. Chem. Soc. 144(45), 20653–20660 (2022).

[146] L.C. Davies, S.J. Jenkins, J.E. Allen, P.R. Taylor, Tissue-resident macrophages. Nat. Immunol. 14(10), 986–995 (2013).

[147] J. He, C. Li, L. Ding, Y. Huang, X. Yin et al., Tumor targeting strategies of smart fluorescent nanoparticles and their applications in cancer diagnosis and treatment. Adv. Mater. 31(40), e1902409 (2019).

[148] D. Zhang, J. He, M. Zhou, Radiation-assisted strategies provide new perspectives to improve the nanoparticle delivery to tumor. Adv. Drug Deliv. Rev. 193, 114642 (2023).

[149] S. Jeon, E. Jun, H. Chang, J.Y. Yhee, E.Y. Koh et al., Prediction the clinical EPR effect of nanoparticles in patient-derived xenograft models. J. Controll. Release 351, 37–49 (2022).

[150] L. Xu, M. Xu, X. Sun, N. Feliu, L. Feng et al., Quantitative comparison of gold nanoparticle delivery via the enhanced permeation and retention (EPR) effect and mesenchymal stem cell (MSC)-based targeting. ACS Nano 17(3), 2039–2052 (2023).

[151] S. Thakkar, D. Sharma, K. Kalia, R.K. Tekade, Tumor microenvironment targeted nanotherapeutics for cancer therapy and diagnosis: A review. Acta Biomater. 101, 43–68 (2020).

[152] G. Yang, S.Z.F. Phua, A.K. Bindra, Y. Zhao, Degradability and clearance of inorganic nanoparticles for biomedical applications. Adv. Mater. (2019).

[153] K. Huang, H. Ma, J. Liu, S. Huo, A. Kumar et al., Size-dependent localization and penetration of ultrasmall gold nanoparticles in cancer cells, multicellular spheroids, and tumors in vivo. ACS Nano 6(5), 4483–4493 (2012).

[154] B. Kim, G. Han, B.J. Toley, C.K. Kim, V.M. Rotello et al., Tuning payload delivery in tumour cylindroids using gold nanoparticles. Nat. Nanotechnol. 5(6), 465–472 (2010).

[155] C. Zhou, M. Long, Y. Qin, X. Sun, J. Zheng, Luminescent gold nanoparticles with efficient renal clearance. Angew. Chem. Int. Ed. 50(14), 3168–3172 (2011).

[156] C. Zhou, G. Hao, P. Thomas, J. Liu, M. Yu et al., Near-infrared emitting radioactive gold nanoparticles with molecular pharmacokinetics. Angew. Chem. Int. Ed. 51(40), 10118–10122 (2012).

[157] D. Luo, X. Wang, S. Zeng, G. Ramamurthy, C. Burda et al., Targeted gold nanocluster-enhanced radiotherapy of prostate cancer. Small 15(34), e1900968 (2019).

[158] C. Alric, I. Miladi, D. Kryza, J. Taleb, F. Lux et al., The biodistribution of gold nanoparticles designed for renal clearance. Nanoscale 5(13), 5930–5939 (2013).

[159] Y. Tan, K. He, B. Tang, H. Chen, Z. Zhao et al., Precisely regulated luminescent gold nanoparticles for identification of cancer metastases. ACS Nano 14(10), 13975–13985 (2020).

[160] J. Liu, M. Yu, X. Ning, C. Zhou, S. Yang et al., Pegylation and zwitterionization: Pros and cons in the renal clearance and tumor targeting of near-ir-emitting gold nanoparticles. Angew. Chem. Int. Ed. 52(48), 12572–12576 (2013).

[161] X.D. Zhang, J. Chen, Z. Luo, D. Wu, X. Shen et al., Enhanced tumor accumulation of sub-2 nm gold nanoclusters for cancer radiation therapy. Adv. Healthcare Mater. 3(1), 133–141 (2014).

[162] J. Gao, K. Chen, R. Xie, J. Xie, S. Lee et al., Ultrasmall near-infrared non-cadmium quantum dots for in vivo tumor imaging. Small 6(2), 256–261 (2010).

[163] Y. Wang, X.-P. Yan, Fabrication of vascular endothelial growth factor antibody bioconjugated ultrasmall near-infrared fluorescent Ag2S quantum dots for targeted cancer imaging in vivo. Chem. Commun. 49(32), 3324–3326 (2013).

[164] R. Hu, Y. Fang, M. Huo, H. Yao, C. Wang et al., Ultrasmall Cu2-xS nanodots as photothermal-enhanced fenton nanocatalysts for synergistic tumor therapy at NIR-II biowindow. Biomaterials 206, 101–114 (2019).

[165] J. Shao, J. Zhang, C. Jiang, J. Lin, P. Huang, Biodegradable titanium nitride mxene quantum dots for cancer phototheranostics in NIR-I/II biowindows. Chem. Eng. J. 400, 126009 (2020).

[166] Z. Xu, H. Huang, X. Xiong, X. Wei, X. Guo et al., A near-infrared light-responsive extracellular vesicle as a “trojan horse” for tumor deep penetration and imaging-guided therapy. Biomaterials 269, 120647 (2021).

[167] X. Yu, A. Li, C. Zhao, K. Yang, X. Chen et al., Ultrasmall semimetal nanoparticles of bismuth for dual-modal computed tomography/photoacoustic imaging and synergistic thermoradiotherapy. ACS Nano 11(4), 3990–4001 (2017).

[168] L. Wen, L. Chen, S. Zheng, J. Zeng, G. Duan et al., Ultrasmall biocompatible WO3-x nanodots for multi-modality imaging and combined therapy of cancers. Adv. Mater. 28(25), 5072–5079 (2016).

[169] D. Liu, X. Dai, W. Zhang, X. Zhu, Z. Zha et al., Liquid exfoliation of ultrasmall zirconium carbide nanodots as a noninflammatory photothermal agent in the treatment of glioma. Biomaterials 292, 121917 (2023).

[170] J. Liu, M. Yu, C. Zhou, S. Yang, X. Ning et al., Passive tumor targeting of renal-clearable luminescent gold nanoparticles: Long tumor retention and fast normal tissue clearance. J. Am. Chem. Soc. 135(13), 4978–4981 (2013).

[171] K. He, Y. Tan, Z. Zhao, H. Chen, J. Liu, Weak anchoring sites of thiolate-protected luminescent gold nanoparticles. Small 17(38), e2102481 (2021).

[172] H.S. Choi, B.I. Ipe, P. Misra, J.H. Lee, M.G. Bawendi et al., Tissue- and organ-selective biodistribution of nir fluorescent quantum dots. Nano Lett. 9(6), 2354–2359 (2009).

[173] S. Huo, S. Chen, N. Gong, J. Liu, X. Li et al., Ultrasmall gold nanoparticles behavior in vivo modulated by surface polyethylene glycol (PEG) grafting. Bioconjugate Chem. 28(1), 239–243 (2017).

[174] Y. Kong, D. Santos-Carballal, D. Martin, N. N. Sergeeva, W. Wang et al., A NIR-II-emitting gold nanocluster-based drug delivery system for smartphone-triggered photodynamic theranostics with rapid body clearance. Mater. Today 51, 96–107 (2021). https://doi.org/10.1016/j.mattod.2021.09.022

[175] T. Zhou, J. Zhu, L. Gong, L. Nong, J. Liu, Amphiphilic block copolymer-guided in situ fabrication of stable and highly controlled luminescent copper nanoassemblies. J. Am. Chem. Soc. 141(7), 2852–2856 (2019).

[176] Z.L. Tyrrell, Y. Shen, M. Radosz, Fabrication of micellar nanoparticles for drug delivery through the self-assembly of block copolymers. Prog. Polymer. Sci. 35(9), 1128–1143 (2010).

[177] L. Nong, T. Zhou, H. Chen, B. Tang, J. Liu, Growth regulation of luminescent gold nanoparticles directed from amphiphilic block copolymers: highly-controlled nanoassemblies toward tailored in-vivo transport. Sci. China Chem. 64(1), 157–164 (2020).

[178] K. Bourzac, News feature: cancer nanomedicine, reengineered. Proc. Natl. Acad. Sci. U. S. A. 113(45), 12600–12603 (2016).

[179] Q. Yuan, Y. Wang, L. Zhao, R. Liu, F. Gao et al., Peptide protected gold clusters: chemical synthesis and biomedical applications. Nanoscale 8(24), 12095–12104 (2016).

[180] S. Dixit, T. Novak, K. Miller, Y. Zhu, M.E. Kenney et al., Transferrin receptor-targeted theranostic gold nanoparticles for photosensitizer delivery in brain tumors. Nanoscale 7(5), 1782–1790 (2015).

[181] X. Ran, Z. Wang, F. Pu, Z. Liu, J. Ren et al., Aggregation-induced emission-active Au nanoclusters for ratiometric sensing and bioimaging of highly reactive oxygen species. Chem. Commun. 55(100), 15097–15100 (2019).

[182] J. Xia, X. Wang, S. Zhu, L. Liu, L. Li, Gold nanocluster-decorated nanocomposites with enhanced emission and reactive oxygen species generation. ACS Appl. Mater. Interfaces 11(7), 7369–7378 (2019).

[183] N. Li, Y. Chen, Y.M. Zhang, Y. Yang, Y. Su et al., Polysaccharide-gold nanocluster supramolecular conjugates as a versatile platform for the targeted delivery of anticancer drugs. Sci. Rep. 4, 4164 (2014).

[184] M.S. Muthu, R.V. Kutty, Z. Luo, J. Xie, S.S. Feng, Theranostic vitamin E TPGS micelles of transferrin conjugation for targeted co-delivery of docetaxel and ultra bright gold nanoclusters. Biomaterials 39, 234–248 (2015).

[185] Y. Wang, J.T. Chen, X.P. Yan, Fabrication of transferrin functionalized gold nanoclusters/graphene oxide nanocomposite for turn-on near-infrared fluorescent bioimaging of cancer cells and small animals. Anal. Chem. 85(4), 2529–2535 (2013).

[186] A. Retnakumari, S. Setua, D. Menon, P. Ravindran, H. Muhammed et al., Molecular-receptor-specific, non-toxic, near-infrared-emitting Au cluster-protein nanoconjugates for targeted cancer imaging. Nanotechnology 21(5), 055103 (2010).

[187] C. Ding, Y. Tian, Gold nanocluster-based fluorescence biosensor for targeted imaging in cancer cells and ratiometric determination of intracellular pH. Biosens. Bioelectron. 65, 183–190 (2015).

[188] Y. Wang, S. Ma, Z. Dai, Z. Rong, J. Liu, Facile in situ synthesis of ultrasmall near-infrared-emitting gold glyconanoparticles with enhanced cellular uptake and tumor targeting. Nanoscale 11(35), 16336–16341 (2019).

[189] S. Su, H. Wang, X. Liu, Y. Wu, G. Nie, IRGD-coupled responsive fluorescent nanogel for targeted drug delivery. Biomaterials 34(13), 3523–3533 (2013).

[190] G. Liang, X. Jin, S. Zhang, D. Xing, RGD peptide-modified fluorescent gold nanoclusters as highly efficient tumor-targeted radiotherapy sensitizers. Biomaterials 144, 95–104 (2017).

[191] Z. Du, Z. He, J. Fan, Y. Huo, B. He et al., Au4 cluster inhibits human thioredoxin reductase activity via specifically binding of au to cys189. Nano Today 47, 101686 (2022).

[192] J. Zhang, A. Rakhimbekova, X. Duan, Q. Yin, C.A. Foss et al., A prostate-specific membrane antigen activated molecular rotor for real-time fluorescence imaging. Nat. Commun. 12(1), 5460 (2021).

[193] X. Han, Z. He, W. Niu, C. Zhang, Z. Du et al., The precise detection of HER-2 expression in breast cancer cell via Au25 probes. Nanomaterials 12(6), 923 (2022).

[194] Y. Wang, J. Chen, J. Irudayaraj, Nuclear targeting dynamics of gold nanoclusters for enhanced therapy of HER2+ breast cancer. ACS Nano 5(12), 9718–9725 (2011).

[195] Y. Tao, M. Li, B. Kim, D.T. Auguste, Incorporating gold nanoclusters and target-directed liposomes as a synergistic amplified colorimetric sensor for HER2-positive breast cancer cell detection. Theranostics 7(4), 899–911 (2017).

[196] H. Xu, J. Ding, Y. Du, L. Li, Y. Li et al., Aptamer-functionalized AuNCs nanogel for targeted delivery of docosahexaenoic acid to induce browning of white adipocytes. J. Mater. Chem. B. 11(22), 4972–4979 (2023).

[197] K. Yu, X. Hai, S. Yue, W. Song, S. Bi, Glutathione-activated DNA-Au nanomachine as targeted drug delivery platform for imaging-guided combinational cancer therapy. Chem. Eng. J. 419, 129535 (2021).

[198] J. Carvalho, J. Lopes-Nunes, B. Vialet, T. Rosado, E. Gallardo et al., Nanoaggregate-forming lipid-conjugated AS1411 aptamer as a promising tumor-targeted delivery system of anticancer agents in vitro. Nanomedicine 36, 102429 (2021).

[199] D. Chen, B. Li, S. Cai, P. Wang, S. Peng et al., Dual targeting luminescent gold nanoclusters for tumor imaging and deep tissue therapy. Biomaterials 100, 1–16 (2016).

[200] B. Feng, Y. Xing, J. Lan, Z. Su, F. Wang, Synthesis of muc1 aptamer-stabilized gold nanoclusters for cell-specific imaging. Talanta 212, 120796 (2020).

[201] J. Liu, Q. Chen, L. Feng, Z. Liu, Nanomedicine for tumor microenvironment modulation and cancer treatment enhancement. Nano Today 21, 55–73 (2018).

[202] Y. Zi, K. Yang, J. He, Z. Wu, J. Liu et al., Strategies to enhance drug delivery to solid tumors by harnessing the EPR effects and alternative targeting mechanisms. Adv. Drug Deliv. Rev. 188, 114449 (2022).

[203] Z. Luo, Z. Yi, X. Liu, Surface engineering of lanthanide nanoparticles for oncotherapy. Acc. Chem. Res. 56(4), 425–439 (2023).

[204] X. Yang, C. Xu, X. Zhang, P. Li, F. Sun et al., Development of sulfonamide-functionalized charge-reversal aie photosensitizers for precise photodynamic therapy in the acidic tumor microenvironment. Adv. Funct. Mater. 33(30), 2300746 (2023).

[205] R. Sun, Y. Zhang, X. Lin, Y. Piao, T. Xie et al., Aminopeptidase n-responsive conjugates with tunable charge-reversal properties for highly efficient tumor accumulation and penetration. Angew. Chem. Int. Ed. 62(9), e202217408 (2023).

[206] M. Yu, C. Zhou, L. Liu, S. Zhang, S. Sun et al., Interactions of renal-clearable gold nanoparticles with tumor microenvironments: vasculature and acidity effects. Angew. Chem. Int. Ed. 56(15), 4314–4319 (2017).

[207] Y. Tan, L. Liu, Y. Wang, J. Liu, pH-regulated surface plasmon absorption from ultrasmall luminescent gold nanoparticles. Adv. Opt. Mater. 6(10), 1701324 (2018).

[208] M. Zhou, X. Du, H. Wang, R. Jin, The critical number of gold atoms for a metallic state nanocluster: resolving a decades-long question. ACS Nano 15(9), 13980–13992 (2021).

[209] C. Zhang, Z. Zhou, Q. Qian, G. Gao, C. Li et al., Glutathione-capped fluorescent gold nanoclusters for dual-modal fluorescence/X-ray computed tomography imaging. J. Mater. Chem. B 1(38), 5045–5053 (2013).

[210] K. Hayashi, M. Nakamura, H. Miki, S. Ozaki, M. Abe et al., Gold nanoparticle cluster-plasmon-enhanced fluorescent silica core-shell nanoparticles for X-ray computed tomography-fluorescence dual-mode imaging of tumors. Chem. Commun. 49(46), 5334–5336 (2013).

[211] C. Xu, Y. Wang, C. Zhang, Y. Jia, Y. Luo et al., AuGd integrated nanoprobes for optical/MRI/CT triple-modal in vivo tumor imaging. Nanoscale 9(13), 4620–4628 (2017).

[212] G. Jarockyte, M. Stasys, V. Poderys, K. Buivydaite, M. Pleckaitis et al., Biodistribution of multimodal gold nanoclusters designed for photoluminescence-SPET/CT imaging and diagnostic. Nanomaterials (2022).

[213] H. Hu, P. Huang, O.J. Weiss, X. Yan, X. Yue et al., PET and NIR optical imaging using self-illuminating 64Cu-doped chelator-free gold nanoclusters. Biomaterials 35(37), 9868–9876 (2014).

[214] X. Chen, W. Niu, Z. Du, Y. Zhang, D. Su et al., 64Cu radiolabeled nanomaterials for positron emission tomography (PET) imaging. Chin. Chem. Lett. 33(7), 3349–3360 (2022).

[215] T. Wang, Y. Chen, B. Wang, M. Wu, Recent progress of second near-infrared (NIR-II) fluorescence microscopy in bioimaging. Front. Physiol. 14, 1126805 (2023).

[216] Y. Guo, J. Hu, P. Wang, H. Yang, S. Liang et al., In vivo NIR-II fluorescence lifetime imaging of whole-body vascular using high quantum yield lanthanide-doped nanoparticles. Small 19(35), 2300392 (2023).

[217] Y. Dai, F. Zhang, K. Chen, Z. Sun, Z. Wang et al., An activatable phototheranostic nanoplatform for tumor specific NIR-II fluorescence imaging and synergistic nir-ii photothermal-chemodynamic therapy. Small 19(22), e2206053 (2023).

[218] D. Gao, Y. Li, Y. Wu, Y. Liu, D. Hu et al., Albumin-consolidated aiegens for boosting glioma and cerebrovascular NIR-II fluorescence imaging. ACS Appl. Mater. Interfaces 15(1), 3–13 (2023).

[219] H. Ma, J. Wang, X.-D. Zhang, Near-infrared II emissive metal clusters: From atom physics to biomedicine. Coord. Chem. Rev. 448, 214184 (2021).

[220] Y. Huang, K. Chen, L. Liu, H. Ma, X. Zhang et al., Single atom-engineered NIR-II gold clusters with ultrahigh brightness and stability for acute kidney injury. Small 19(30), 2300145 (2023).

[221] K. Zhou, W. Cai, Y. Tan, Z. Zhao, J. Liu, Hihly controllable nanoassemblies of luminescent gold nanoparticles with abnormal disassembly-induced emission enhancement for in vivo imaging applications. Angew. Chem. Int. Ed. 61(47), e202212214 (2022).

[222] B. Tang, W. Xia, W. Cai, J. Liu, Luminescent gold nanoparticles with controllable hydrophobic interactions. Nano Lett. 22(20), 8109–8114 (2022).

[223] D. Li, Q. Liu, Q. Qi, H. Shi, E.C. Hsu et al., Gold nanoclusters for NIR-II fluorescence imaging of bones. Small 16(43), e2003851 (2020).

[224] H. Liu, G. Hong, Z. Luo, J. Chen, J. Chang et al., Atomic-precision gold clusters for NIR-II imaging. Adv. Mater. 31(46), e1901015 (2019).

[225] Z. Pang, W. Yan, J. Yang, Q. Li, Y. Guo et al., Multifunctional gold nanoclusters for effective targeting, near-infrared fluorescence imaging, diagnosis, and treatment of cancer lymphatic metastasis. ACS Nano 16(10), 16019–16037 (2022).

[226] M. Liang, Q. Hu, S. Yi, Y. Chi, Y. Xiao, Development of an Au nanoclusters based activatable nanoprobe for NIR-II fluorescence imaging of gastric acid. Biosens. Bioelectron. 224, 115062 (2023).

[227] A. Baghdasaryan, F. Wang, F. Ren, Z. Ma, J. Li et al., Phosphorylcholine-conjugated gold-molecular clusters improve signal for lymph node NIR-II fluorescence imaging in preclinical cancer models. Nat. Commun. 13(1), 5613 (2022).

[228] X. Jiang, B. Du, S. Tang, J.T. Hsieh, J. Zheng, Photoacoustic imaging of nanoparticle transport in the kidneys at high temporal resolution. Angew. Chem. Int. Ed. 58(18), 5994–6000 (2019).

[229] H. Cui, D. Hu, J. Zhang, G. Gao, Z. Chen et al., Gold nanoclusters-indocyanine green nanoprobes for synchronous cancer imaging, treatment, and real-time monitoring based on fluorescence resonance energy transfer. ACS Appl. Mater. Interfaces 9(30), 25114–25127 (2017).

[230] H. Zhu, Y. Zhou, Y. Wang, S. Xu, T.D. James et al., Stepwise-enhanced tumor targeting of near-infrared emissive Au nanoclusters with high quantum yields and long-term stability. Anal. Chem. 94(38), 13189–13196 (2022).

[231] L.V. Nair, R.V. Nair, S.J. Shenoy, A. Thekkuveettil, R.S. Jayasree, Blood brain barrier permeable gold nanocluster for targeted brain imaging and therapy: an in vitro and in vivo study. J. Mater. Chem. B 5(42), 8314–8321 (2017).

[232] D. Sultan, D. Ye, G.S. Heo, X. Zhang, H. Luehmann et al., Focused ultrasound enabled trans-blood brain barrier delivery of gold nanoclusters: effect of surface charges and quantification using positron emission tomography. Small 14(30), e1703115 (2018).

[233] C.A. Smith, C.A. Simpson, G. Kim, C.J. Carter, D.L. Feldheim, Gastrointestinal bioavailability of 2.0 nm diameter gold nanoparticles. ACS Nano 7(5), 3991–3996 (2013).